Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Study to Observe Safety and Efficacy of TAF in Patients With Chronic Hepatitis B

NCT03489239 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT03489239
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03489239 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Study to Observe Safety and Efficacy of TAF in Patients With Chronic Hepatitis B
Lead sponsor
Thomas Jefferson University
Phase
Phase 3
Overall status
Active, not recruiting
Start date
November 16, 2017
Completion date
September 16, 2020
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b